nH1N1 Influenza Vaccine
H1N1 Vaccine is NOW available at San Francisco Public Health Dept Clinics at the times and locations listed in their flyer.
This vaccine is for All people from 6 months through 24 years of age and individuals in High Risk Groups
The FDA Approved Vaccines for 2009 nH1N1 Influenza Virus on September 15, 2009.
One dose of the 2009 H1N1 vaccines have been shown to produce a robust immune response in most healthy adults eight to 10 days after a single dose.
The nH1N1 Vaccine is a monovalent vaccine and is only effective against H1N1 Influenza and is not intended to replace the trivalent seasonal flu vaccine.
The nH1N1 Vaccine is intended to be used alongside seasonal flu vaccine to protect people against the various types of Influenza. Seasonal flu and novel H1N1 vaccines may be administered on the same day.
The nH1N1 vaccines are supplied to medical clinics in three different formulations.
Multi dose bottles of injectable vaccine with Thimerosal
Single dose bottles of injectable vaccine without Thimerosal
Single dose bottles of nasal spray vaccine without Thimerosal
San Francisco State University expects to receive 2100 doses of vaccine in early November, 2009.
100 doses injectable vaccine without Thimersol - for Pregnant clients.
2000 doses injectable vaccine with Thimersol
No doses of live nasal spray vaccine (no Thimersol).
Thimerosal is a mercury-containing preservative.
For more information regarding Thimerosal please see the FDA website on Vaccine Safety.
Screening Questionnaire for Adult Immunization
2009 H1N1 Influenza Inactivated Vaccine (the "flu" shot) Vaccine Infomation Statement (VIS).
Mass nH1N1 Immunization in San Francisco
If you fall into one of the targeted groups listed below, the San Francisco Department of Public Health will be providing the vaccinations through community based clinics to high risk patients without a regular medical home or whose normal provider is not receiving the H1N1 vaccine. The Department of Public Health will not be holding the Mass H1N1 Vaccination Clinc as previously announced. For ongoing updates please check the Influenza (Flu) San Francisco Department of Public Health Communicable Disease Prevention Unit website.
Mass nH1N1 Immunization @ SF State
San Francisco State SHS in conjunction with the Nursing Faculty and Students will be providing mass nH1N1 vaccinations soon after the vaccine is received.
Please see this site and SFSU on Twitter for updates on the location and times for the SF State mass nH1N1 vaccination program.
If you are under 18 years of age, you must also complete an authorization for consent for medical services. This form must signed by your parent or guardian. Please bring the signed form with you to get your vaccine.
Who Should Get The nH1N1 Vaccine?
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) recommends vaccine against novel H1N1 influenza A (nH1N1) used for Five key populations.
pregnant women,
persons between the ages of 6 months through 24 years of age,
and people from ages 25 through 64 years who are at higher risk for novel H1N1 because of chronic health disorders or compromised immune systems.
health care and emergency medical services personnel,
people who live with or care for children younger than 6 months of age
People with severe or life-threatening allergies to chicken eggs, or to any other substance in the vaccine, should not be vaccinated with these vaccines.
For the injected vaccine, the most common side effect is soreness at the injection site. Other side effects may include mild fever, body aches, and fatigue for a few days after the inoculation.
For the nasal spray vaccine, the most common side effects include runny nose or nasal congestion for all ages, sore throats in adults, and -- in children 2 to 6 years old -- fever.
Listed below are the formal CDC Vaccine Information Statements (VIS) for each of the vaccines:
2009 H1N1 Influenza Inactivated Vaccine (the "flu" shot) Vaccine Infomation Statement
2009 H1N1 Influenza Live, Attenuated Vaccine (the nasal spray vaccine) Vaccine Information Statement
The key groups listed above total approximately 159 million people in the USA.
Although the nH1N1 vaccine will be not be immediately available for everyone the FDA does NOT anticipate any 2009 nH1N1 Flu vaccine shortages.
For further information see CDC's nH1N1 Vaccine webpage
